Home Online Features Bio-Thera Solutions Announces Exclusive Commercialization and License Agreement with Intas Pharmaceuticals for BAT2506, a Proposed Biosimilar Referencing Simponi® (golimumab), in the United States of America

Bio-Thera Solutions Announces Exclusive Commercialization and License Agreement with Intas Pharmaceuticals for BAT2506, a Proposed Biosimilar Referencing Simponi® (golimumab), in the United States of America

Hand-out

Press Releases

February 10, 2025

Bio-Thera Solutions Announces Exclusive Commercialization and License Agreement with Intas Pharmaceuticals for BAT2506, a Proposed Biosimilar Referencing Simponi® (golimumab), in the United States of America

By Bio-Thera Solutions, Ltd

GUANGZHOU, China, Feb. 10, 2025 /PRNewswire/ -- Bio-Thera Solutions (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of innovative therapies and biosimilars, today announced the company has reached an exclusive

{"bradfordera-website":"Website"}

The Bradford Era

Local & Social

Local News

City audit shows what a difference a day makes

By MARCIE SCHELLHAMMER marcie@bradfordera.com

December 4, 2025

HARRISBURG — There's an old saying that Rome wasn't built in a day, but one day has cost the City of Bradford more than $6,000 in a recent audit. Audi...

Comment & Opinion, Opinion

White House needs pro-growth agenda

December 4, 2025

Democrats see an opportunity to hammer Republicans and the White House on “affordability,” counting on voters to forget that inflation soared to 9% in...

Local News

Maple syrup production, beekeeping webinar

December 4, 2025

UNIVERSITY PARK — For those interested in the fundamentals of beekeeping or maple syrup production, Penn State Extension will offer a webinar, “Living...

Comment & Opinion, Opinion

We are giving up our most valuable assets in race with China

December 4, 2025

Losing the competition with China is not an option — but it could become a reality without greater investment in America, the American people and our ...

{"to-print":"To print", "bradfordera-website":"Website"}

Comment & Opinion, Opinion

Judgment day or payday? Pennsylvanians weigh AI revolution

By ATHAN KOUTSIOUROUMBUS RealClearPennsylvania

December 4, 2025

In the four decades since James Cameron introduced the world to a cybernetic assassin sent from a dystopian future, new RealClearPennsylvania/Emerson ...

{"to-print":"To print", "bradfordera-website":"Website"}

This Week's Ads

Current e-Edition

Already a subscriber? Click the image to view the latest e-edition.

Don't have a subscription? Click here to see our subscription options.

Mobile App

Download Now

The Bradford Era mobile app brings you the latest local breaking news, updates, and more. Read the Bradford Era on your mobile device just as it appears in print.

Help Our Community

Please help local businesses by taking an online survey to help us navigate through these unprecedented times. None of the responses will be shared or used for any other purpose except to better serve our community. The survey is at: www.pulsepoll.com $1,000 is being awarded. Everyone completing the survey will be able to enter a contest to Win as our way of saying, "Thank You" for your time. Thank You!